We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial, Eli Lilly Australia Pty Ltd, CON-1219
Product name
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1219
Duration
The consent is effective from 22 March 2024 until 31 March 2025.
Standard
paragraph 8 (1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product labels do not include the current address for the sponsor, and say
North Ryde, NSW in place of Sydney, NSW
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines